Saturday, January 14, 2006


Conference Report - Hepatitis C Infection (Hep C Chronic Fatigue)


Conference Report - Hepatitis C Infection
Michael P. Manns, MD, and Heiner Wedemeyer, MD, discuss the latest issues in the treatment of chronic hepatitis C, with a view toward future therapies. ... Hepatitis C Infection: Optimizing Treatment, Patient Management, and Basic Aspects ... Introduction -- Therapy of Chronic Hepatitis C Infection ...

Tattoos equal 9% risk for hepatitis c infection
Hepatitis C. Infection Control: Issues and Answers for Health Care Workers. http://www.hivdent.org/infctl/hepatiti.htm. Tattooing A Major Route Of Hepatitis C Infection ... The risk of hepatitis C infection was also higher among patients with ...

Hepatitis C - Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted - information page with HONselect
... However, in a significant number of cases, the source of hepatitis C infection is unknown. ...

Friday, January 13, 2006


Sex and HCV (Hep C Chronic Fatigue)


Sex and HCV
The risk of sexual transmission of hepatitis C virus (HCV) infection was ... Sexual transmission of HCV between men who have sex with men and women who have ...

Hepatitis C Top Articles
Chronic hepatitis C virus (HCV) infection affects approximately 3 million people in ... Is HCV Viral Load a Predictor of Progression of Chronic Hepatitis C? ...

Hepatitis C Resources and Information
Hepatitis C Resources and Information is a website with up-to-date hepatitis C weblinks, hep C information, HCV defined and undefined, inspiration for ...

Deutsches Hepatitis C Forum eV - International Homepage
- [ Translate this page ]Deutsches Hepatitis C Forum eV - International Homepage is a source of information about the rising epidemic: Hepatitis C. What it is, treatments, ...

TAG: Hepatitis C Virus (HCV) and HIV/HCV Coinfection (Hep C Chronic Fatigue)


TAG: Hepatitis C Virus (HCV) and HIV/HCV Coinfection
Cover Volume I: Clinical Science Executive Summary I. Epidemiology & Transmission of Hepatitis C II. Natural History of Hepatitis C III. Natural History of HCV in HIV Coinfection IV. Diagnostics

Hepatitis C | SciClone Pharmaceuticals International
Therapies for Viral Hepatitis C Virus and Related Viruses. Kyoto, Japan, 1997. 3. Sherman K. Data on file. 4. Rasi G, et al. J Viral Hepat. 1996;3:191-196. 5

Serologic Tests Used to Diagnose Hepatitis C
Viral Hepatitis C - Frequently Asked Questions Nutrition & Hep C Nutrition and Diet Recommendations for people with Chronic Hepatitis

eMedicine - Hepatitis, Viral : Article by David C Wolf, MD, FACP, FACG
Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology 1996 Oct; 24(4): 778-89 [Medline] . Poynard T, McHutchison J, Davis GL, et

Thursday, January 12, 2006


Doctor: Getting the Most from Your Doctor s Appointment (Hep C Chronic Fatigue)


Doctor: Getting the Most from Your Doctor s Appointment
Title: Doctor: Getting the Most from Your Doctor s AppointmentCategory: Doctor's ViewsCreated: 5/13/2005Last Editorial Review: 5/13/2005

Ultrasound
Title: UltrasoundCategory: Procedures and TestsCreated: 12/31/1997Last Editorial Review: 10/15/2005

Fatty Liver
Title: Fatty LiverCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 8/29/2005

Two Studies Recruiting HCV Patients
Sho-saiko-to is the number one liver remedy in Japan. It has been prescribed to over 1.5 million patients (in Japan, doctors medically prescribe certain natural remedies, just like doctors prescribe pharmaceutical drugs in the U.S.). Based on the large body...

Indenix is Nearing Phase III for Valopicitabine
It is always good to see progress with alternatives to current medical therapy for HCV. Even though companies that are working on solutions to be used with interferon are not really offering anything groundbreaking or revolutionary, it does continue the...

Cubist Pharmaceuticals Reports Results From Phase 2 Study Hepex-B(TM), Which Was Licensed From XTLbio (Hep C Chronic Fatigue)


Cubist Pharmaceuticals Reports Results From Phase 2 Study Hepex-B(TM), Which Was Licensed From XTLbio
FinanzNachrichten - Dec 22 12:09 AM
REHOVOT, Israel, December 22 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. ( Nachrichten ) ("XTLbio") announces that Cubist Pharmaceuticals, ( Nachrichten ) Inc. today provided data from a recently concluded Phase 2 study of HepeX-B(TM) which was licensed to Cubist by XTLbio in 2004. In the Phase 2 study, HepeX-B was studied as maintenance therapy to prevent reinfection with hepatitis B Save to My Web

Human Genome Sciences Reports on Progress Toward Commercialization and Announces 2006 Goals at JPMorgan Healthcare
[Press Release] PR Newswire via Yahoo! Finance - Jan 10 4:10 AM
Human Genome Sciences, Inc. will report on its progress toward commercialization and announce 2006 goals during a presentation tomorrow by President and Chief Executive Officer H. Thomas Watkins to financial analysts and investors at the 24th Annual JPMorgan Healthcare Conference in San Francisco.Save to My Web

Human Genome Sciences Announces Decision to Spin Off CoGenesys Division as an Independent Company
[Press Release] PR Newswire via Yahoo! Finance - Dec 13 1:05 PM
Human Genome Sciences, Inc. today announced that it has decided to spin off its CoGenesys division as an independent company that will focus on the early development of selected gene-based product opportunities and the monetization of certain Human Genome Sciences intellectual property and technology assets.Save to My Web

Chronic Hepatitis C Treatment, Peg-Intron(R) And Rebetol(R) Approved In Japan
Medical News Today - Dec 27 4:15 PM
Schering-Plough Corporation (NYSE: SGP) announced that Schering-Plough K.K., the company's country operations in Japan, has received marketing approval for a new, additional indication for PEG-INTRON(R) (peginterferon alfa-2b) Powder for Injection in combination with REBETOL(R) (ribavirin) Capsules -- the treatment of chronic hepatitis C in adult patients other than those with genotype 1 virus Save to My Web

Hepatitis C Patients Taxing Medical System
HealthDay via Yahoo! News - Dec 30 11:02 AM
FRIDAY, Dec. 30 (HealthDay News) -- The use of health-care resources by hepatitis C patients in the United States has been increasing by 25 percent to 30 percent a year, says a Duke University study in the December issue of Hepatology.Save to My Web

Tuesday, January 10, 2006


Paradox in Risk of Liver Disease: Presented at EACS (Hep C Chronic Fatigue)


Paradox in Risk of Liver Disease: Presented at EACS
DG News - Dec 12, 2005... HAART Based on Protease Inhibitors Is Associated with Lower Liver Fibrosis Progression among HIV Infected Patients with Chronic Hepatitis C. Abstract PS7/5. Is ...

Human Genome Sciences Announces Decision to Spin Off CoGenesys ...
PR Newswire (press release), NY - Dec 13, 2005... of systemic lupus erythematosus (SLE) and rheumatoid arthritis; Albuferon(TM) (albumin- interferon-alpha) for the treatment of chronic hepatitis C; and HGS ...

FDA Approvals: RPS Adeno Detector, Elecsys NT-proBNP Test, TBA ...
Medscape (subscription) - Jan 6, 2006... hepatitis, liver sclerosis, and liver cancer; monitoring of therapeutic efficacy in patients receiving interferon for chronic hepatitis C virus infection, and ...

Higher doses of pegylated interferon or ribavirin improve ...
Aidsmap, UK - Dec 8, 2005... Weight-based ribavirin dosing (WBD) increases sustained viral response (SVR) in patients with chronic hepatitis C (CHC): final results of the WIN-R study, a US ...

Hepatitis C patients to burden NHS
Daily Mail - UK, UK - Dec 13, 2005... Dr Helen Harris, a hepatitis C expert at the HPA, said: "Most individuals with chronic hepatitis C infection can be successfully treated, but the success of ...

USA TODAY Cover Story Features Lipid Sciences' HDL Therapy in ' ... (Hep C Chronic Fatigue)


USA TODAY Cover Story Features Lipid Sciences' HDL Therapy in ' ...
Market Wire (press release) - 8 hours ago... Conditions that could potentially be impacted by this technology include HIV, Hepatitis B and Hepatitis C, West Nile, SARS and influenza. ...

Valeant Pharmaceuticals Completes Acquisition of Hep-C Drug ...
Finanzen.net, Germany - Jan 3, 2006... International (NYSE:VRX) todayannounced that it has completed its acquisition of the United Statesand Canadian rights to the hepatitis C drug Infergen(R ...

Valeant Pharmaceuticals Completes Acquisition of Hep-C Drug ...
Business Wire (press release), CA - Jan 3, 2006... International (NYSE:VRX) today announced that it has completed its acquisition of the United States and Canadian rights to the hepatitis C drug Infergen(R ...

MedMira Granted Hepatitis C Patent in Europe
PR Newswire (press release), NY - Jan 3, 2006... first major patent on its rapid diagnostic technology in Europe, and paves the way for the world's first combination HIV and Hepatitis C instant rapid test. ...

Two new cases of hepatitis C this year
Shetland Times, UK - Dec 30, 2005THE NUMBER of people in Shetland diagnosed with the hepatitis C virus is running at just over a quarter of the national average rate. ...

A Summary of Chronic Hepatitis C InfectionHepatitis C (Hep C Chronic Fatigue)

A Summary of Chronic Hepatitis C Infection

Hepatitis C is a stealthy virus that mutates while hiding in liver cells and other organ cells like the spleen and gall bladder. The fact that the viral cells "hide" makes it very difficult for the body's immune system to eradicate it. Hepatitis C is a slowly progressing disease sometimes taking many years until symptoms are noticeable. It is at this point that the virus has reached advanced chronic stage and becomes difficult to eradicate. Hepatitis C results in 8,000 to 10,000 deaths annually. Hepatitis C is also the leading cause of liver transplants in the U.S.

Hepatitis C infection is caused by blood contact with someone who has the virus infection himself. The transmission of the virus can occur by illicit drug use with needles, sharing toothbrushes or razors with an infected person, by sexual means, by unsanitary tattooing or by exposure to blood at your workplace (like a hospital or blood bank). Some HCV infection may have been caused by receiving blood from a transfusion prior to 1992.

Hepatitis C is diagnosed via a blood test. Usually, the first thing that is noticed is that the liver enzyme levels for ALT and AST are elevated well above normal levels. Further investigation via HCV-RNA testing identifies whether the Hepatitis C virus is in your blood or not. Other tests for HCV include qualitative viral load tests, which measure the RNA particles in your blood. If you are being treated for HCV, your doctor is probably using either a HCV-RNA or viral load test to determine the effectiveness of the treatment.

The symptoms of Hepatitis C infection often do not occur in a person until 20 years after he/she had been infected. Since the HCV infects the liver and the liver is the organ in the body that makes all the energy for our daily activities possible, liver function deterioration often results in fatigue. Fatigue is the primary complaint or symptom of HCV infection. Other more severe symptoms are jaundice (yellowing of the skin/eyes), bile retention (which can cause jaundice), portal vein hypertension, skin rashes and itching, and autoimmune problems resulting from your body's immune system attacking normal cells.

Long term HCV infection may result in fibrosis or even cirrhosis of the liver. Fibrosis results from unchecked liver inflammation. As the HCV infection progresses, the damage to the liver results in scarring or hardening of the liver cells (fibrosis). Long term fibrosis may lead to cirrhosis which is when the scarring from fibrosis overtakes the normal liver cell structure causing deformity and loss of function in the liver. About 15%-20% of HCV patients end up with cirrhosis. A liver biopsy is currently the most accurate means of determining the amount of inflammation and fibrosis the liver has sustained.

Hepatitis C progression in the body can take several years or even decades to come to chronic stage or to a stage where severe liver damage is evident. This period of time allows a person to determine how to properly treat the disease and to decide on a course of disease management. Currently, the main treatment for HCV infection to eradicate the virus is combo alpha-interferon and Ribavirin. Sometimes a doctor may prescribe interferon alone. Interferon comes in standard form or in pegylated form. Standard form interferon is administered 3 times per week, while the pegylated form is administered only once per week. Your body makes its own interferon, which is a protein that fights viral infection and viral replication.

Hepatitis C may often be managed by taking herbal and vitamin supplements that help your body fight infection and limit inflammation. These supplements help your liver with the inflammation and give it the nutrients it needs to regenerate healthy new cells. Your doctor can recommend alternative or adjunct solutions you may want to try.

Proper treatment of the disease, a healthy and active lifestyle, a good diet, abstinence from alcohol and stress management are important factors in controlling Hepatitis C progression.

About the Author

Greg Lietz is a freelance writer and internet businessman. His main website is http://www.theonlinebizplace.com where he provides content about internet based business opportunities and different niche interests. This article may be freely printed when the bio information is included.

Sunday, January 08, 2006


Ways You Can Get Infected With Hepatitis C(NC)-Hepatitis (Hep C Chronic Fatigue)

Ways You Can Get Infected With Hepatitis C

(NC)-Hepatitis C is spread through contact with infected blood. Here are just some of the ways in which you can be infected with this virus:

Sharing needles, straws, pipes, spoons and other drug-related equipment.

(At least two-thirds of all new hepatitis C infections are drug-use related. Cleaning equipment with bleach does not always effectively kill the virus) p>

Getting a tattoo, body piercing or acupuncture from an operator who does not use sterile equipment or techniques

Being born to a mother with hepatitis C

Getting pierced by a needle or sharp equipment that has infected blood on it ( in a hospital, workplace situation, etc.) p>

People who had blood transfusions before the testing of blood donations became mandatory in 1990 may also be at risk. And, while the risk is low, it is also possible to become infected by sharing personal household articles such as a razor or toothbrush with an infected person. The risk of transmission of hepatitis C during sex is also low, unless both parties have open bleeding sores.

It is estimated that 240, 000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus.

If you think you may be at risk, either now or from past risky activities see a doctor. The virus can be detected with a simple blood test, and there are steps and medications you can take to successfully minimize the effects of the disease if your diagnosis is positive. For more information, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.